Log in
Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
Drug: ONO-7914
Drug: ONO-4538
Subscribe
First Posted Date
2024-08-02
Last Posted Date
2024-08-02
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
204
Registration Number
NCT06535009
Locations
🇯🇵
Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy